...
首页> 外文期刊>Microbial drug resistance: MDR : Mechanisms, epidemiology, and disease >Characterization of clinical multidrug-resistant Escherichia coli and Klebsiella pneumonia isolates, 2007-2009, China
【24h】

Characterization of clinical multidrug-resistant Escherichia coli and Klebsiella pneumonia isolates, 2007-2009, China

机译:2007-2009年中国临床多重耐药性大肠杆菌和肺炎克雷伯菌分离株的鉴定

获取原文
获取原文并翻译 | 示例
           

摘要

Various resistance mechanisms facilitate the emergence and spread of multidrug-resistance (MDR) phenotypes of Escherichia coli and Klebsiella pneumoniae. To elucidate the MDR mechanisms of E. coli and K. pneumoniae in China, we analyzed the antimicrobial susceptibilities of strains isolated from clinical samples in a large tertiary care hospital in Beijing, China, during 2007-2009 and characterized the isolates with a cefotaxime-ciprofloxacin- amikacin (CTX-CIP-AK) resistance pattern. In total, 98 and 52 clinical isolates of E. coli and K. pneumoniae, respectively, with a CTX-CIP-AK resistance pattern were subjected to antimicrobial susceptibility testing and screening of common β-lactamase genes, plasmid-mediated quinolone resistance (PMQR) genes, quinolone resistance-determining region (QRDR) substitutions, and 16S rRNA methylase genes by polymerase chain reaction amplification and DNA sequencing. Pulsed-field gel electrophoresis (PFGE) was used to determine the genetic relatedness of the isolates. Approximately 6.86% and 8.05% of the clinical E. coli and K. pneumoniae isolates, respectively, exhibited MDR phenotypes. The MDR K. pneumoniae isolates exhibited significantly higher ceftazidime resistance than the MDR E. coli isolates (90.4% vs. 76.5%, p = 0.0339); a similar result was noted for piperacillin-tazobactam resistance (28.8% vs. 2%, p = 0.0001). The common resistance determinants among the MDR E. coli and K. pneumoniae isolates were as follows: CTX-M (88.8% vs. 82.7%), PMQR genes (70.4% vs. 90.4%), gyrA mutations (100% vs. 90.4%), and 16S rRNA methylase genes (93.9% vs. 94.2%). Half (50%) of the MDR E. coli isolates belonged to phylogenetic group D, followed by group A (39.8%). For the E. coli isolates, 94 PFGE patterns and 23 clusters were identified, whereas 51 PFGE patterns and 11 clusters were identified for the K. pneumoniae isolates. Clinical E. coli and K. pneumoniae isolates seem to have a low prevalence of MDR phenotypes in China. The great genetic variation indicates a considerable transmission of common resistance determinants, including a high prevalence of QRDR substitutions in E. coli and K. pneumoniae.
机译:多种耐药机制促进了大肠杆菌和肺炎克雷伯菌的多药耐药(MDR)表型的出现和传播。为了阐明中国大肠埃希菌和肺炎克雷伯菌的MDR机制,我们分析了2007年至2009年间在中国北京一家大型三级护理医院从临床样本中分离出的菌株的耐药性,并用头孢噻肟对这些菌株进行了表征。环丙沙星-阿米卡星(CTX-CIP-AK)耐药模式。总共分别对98株和52株具有CTX-CIP-AK耐药模式的大肠埃希菌和肺炎克雷伯菌临床分离株进行了抗药性测试并筛选了常见的β-内酰胺酶基因,质粒介导的喹诺酮耐药性(PMQR)基因,喹诺酮抗性决定区域(QRDR)替代和16S rRNA甲基化酶基因通过聚合酶链反应扩增和DNA测序。脉冲场凝胶电泳(PFGE)用于确定分离物的遗传相关性。临床大肠杆菌和肺炎克雷伯菌分离株分别约有6.86%和8.05%表现出MDR表型。耐多药肺炎克雷伯菌比耐多药大肠杆菌分离株具有更高的头孢他啶耐药性(90.4%对76.5%,p = 0.0339);对于哌拉西林-他唑巴坦的耐药性也观察到了相似的结果(28.8%vs. 2%,p = 0.0001)。 MDR大肠杆菌和肺炎克雷伯菌分离株中常见的耐药性决定因素如下:CTX-M(88.8%对82.7%),PMQR基因(70.4%对90.4%),gyrA突变(100%对90.4) %)和16S rRNA甲基化酶基因(93.9%对94.2%)。 MDR大肠杆菌分离株的一半(50%)属于系统发育组D,其次是A组(39.8%)。对于大肠杆菌分离株,鉴定出94个PFGE图谱和23个簇,而对于肺炎克雷伯菌分离株鉴定出51个PFGE图谱和11个簇。在中国,临床大肠杆菌和肺炎克雷伯菌分离株的MDR表型患病率较低。巨大的遗传变异表明常见的抗性决定簇大量传播,包括在大肠杆菌和肺炎克雷伯菌中QRDR取代的高流行。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号